| Date Filed | Type | Description |
| 08/11/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/11/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/08/2023 |
4
| Sardano Michael (PRESIDENT AND GENERAL COUNSEL) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Bought 1,000 shares
@ $3.7778, valued at
$3.8k
|
|
| 08/08/2023 |
4
| Sardano Joseph C (CEO) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Bought 10,000 shares
@ $3.8574, valued at
$38.6k
|
|
| 08/03/2023 |
8-K
| Quarterly results |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/31/2023 |
4
| Heinrich John (Director) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Bought 10,000 shares
@ $2.86, valued at
$28.6k
|
|
| 05/11/2023 |
4
| Sardano Joseph C (CEO) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Bought 17,075 shares
@ $2.9901, valued at
$51.1k
Bought 7,925 shares
@ $2.995, valued at
$23.7k
|
|
| 05/10/2023 |
4
| O'Rear Samuel (Director) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Bought 2,436 shares
@ $2.9494, valued at
$7.2k
Bought 17,564 shares
@ $2.9987, valued at
$52.7k
|
|
| 05/10/2023 |
4
| Sardano Michael (PRESIDENT AND GENERAL COUNSEL) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Bought 1,000 shares
@ $2.995, valued at
$3k
|
|
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Sardano Michael (PRESIDENT AND GENERAL COUNSEL) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Paid exercise price by delivering 3,745 shares
@ $8.96, valued at
$33.6k
|
|
| 01/11/2023 |
3
| Martinez Magdalena (COO) has filed a Form 3 on Sensus Healthcare, Inc. |
| 01/11/2023 |
3
| Sosa Emiliano (Chief Technology Officer) has filed a Form 3 on Sensus Healthcare, Inc. |
| 01/09/2023 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 09/15/2022 |
4
| Sardano Michael (PRESIDENT AND GENERAL COUNSEL) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Exercised 5,000 shares
@ $5.55, valued at
$27.8k
Sold 5,000 shares
@ $14.1255, valued at
$70.6k
|
|
| 09/07/2022 |
4
| Sardano Joseph C (CEO) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Sold 10,000 shares
@ $12.4168, valued at
$124.2k
Sold 15,794 shares
@ $12.5647, valued at
$198.4k
Sold 15,794 shares
@ $12.5771, valued at
$198.6k
|
|
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/11/2022 |
4
| Sardano Joseph C (CEO) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Sold 36,093 shares
@ $13.9657, valued at
$504.1k
Sold 93,320 shares
@ $14.1577, valued at
$1.3M
Sold 28,999 shares
@ $14.2149, valued at
$412.2k
|
|
| 08/10/2022 |
4
| O'Rear Samuel (Director) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Sold 10,022 shares
@ $13.9635, valued at
$139.9k
Sold 39,978 shares
@ $14.2642, valued at
$570.3k
|
|
| 08/04/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/25/2022 |
4
| Sardano Michael (PRESIDENT AND GENERAL COUNSEL) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Paid exercise price by delivering 3,935 shares
@ $10.51, valued at
$41.4k
|
|
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/12/2022 |
4
| McCall William H (Director) has filed a Form 4 on Sensus Healthcare, Inc.|
Txns:
| Sold 5,000 shares
@ $7.53, valued at
$37.7k
Sold 5,000 shares
@ $7.55, valued at
$37.8k
|
|
| 05/05/2022 |
8-K
| Quarterly results |
|